{"id":26537,"date":"2024-09-12T11:42:36","date_gmt":"2024-09-12T18:42:36","guid":{"rendered":"https:\/\/ameripharmaspecialty.com\/?p=26537"},"modified":"2024-09-12T11:42:38","modified_gmt":"2024-09-12T18:42:38","slug":"entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease","status":"publish","type":"post","link":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/","title":{"rendered":"Entyvio\uff1a\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u548c\u514b\u7f57\u6069\u75c5\u7684\u9776\u5411\u6cbb\u7597"},"content":{"rendered":"\n<p>Entyvio (vedolizumab) is a medication developed by <a href=\"https:\/\/www.takeda.com\/en-us\/\">Takeda Pharmaceuticals<\/a>. The FDA first approved it on May 20, 2014 [<a href=\"https:\/\/www.fda.gov\/media\/131177\/download\">1<\/a>]. It is used to treat ulcerative colitis (UC) and <a href=\"https:\/\/ameripharmaspecialty.com\/other-health-conditions\/a-complete-overview-of-crohns-disease\/\">Crohn\u2019s disease<\/a>.\u00a0<\/p>\n\n\n\n<div  id=\"call-to-action-8355cfd712380e8c08890dd7742f8222\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\t Speak to a Specialist\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"cta__sub__heading\">\n\t\t\t\t\t\t\tAbout Copay Assistance\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"tel:8777780318\">(877) 778-0318<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<p>Entyvio is a type of medication called a monoclonal antibody that works by targeting specific parts of the immune system. Doing this helps lessen inflammation in the gut, which causes serious symptoms of UC\u00a0and Crohn\u2019s disease. This medication can be especially helpful if other medications don\u2019t give you enough relief.\u00a0<\/p>\n\n\n\n<p>Entyvio is a more focused treatment option that makes managing your condition easier. But, like any other medication, it also has some side effects, some of which can be severe.&nbsp;<\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_82_2 counter-hierarchy ez-toc-counter ez-toc-custom ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#What_Is_Entyvio_Used_To_Treat\" >What Is Entyvio Used To Treat?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#How_It_Works\" >How It Works<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Side_Effects\" >Side Effects<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Common_Side_Effects\" >Common Side Effects<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Serious_Side_Effects\" >Serious Side Effects<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Dosage_and_Treatment\" >Dosage and Treatment<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Cost\" >Cost<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#Entyvio_FAQs\" >Entyvio FAQs<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"What_Is_Entyvio_Used_To_Treat\"><\/span><strong>What Is Entyvio Used To Treat?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Entyvio is FDA-approved&nbsp; to treat the following inflammatory bowel diseases [<a href=\"https:\/\/content.takeda.com\/?contenttype=PI&amp;product=ENTY&amp;language=ENG&amp;country=USA&amp;documentnumber=1\">2<\/a>]:<\/p>\n\n\n\n<p><strong>Ulcerative Colitis (UC):<\/strong> UC is a long-term bowel disease in which your colon and rectum are inflamed. It leads to symptoms like stomach pain, diarrhea, and bleeding from your rectum. Entyvio is used to treat moderate to severe ulcerative colitis.<\/p>\n\n\n\n<p><strong>Crohn\u2019s Disease:<\/strong> This is another type of bowel disease that can cause inflammation anywhere in the digestive tract (from the mouth to the anus). It leads to symptoms like belly pain, severe diarrhea, weight loss, fatigue, and malnutrition. Entyvio can treat moderate to severe Crohn\u2019s disease.<\/p>\n\n\n\n<p>It is usually reserved for people who haven\u2019t had success treating their symptoms with <a href=\"https:\/\/ameripharmaspecialty.com\/ivig\/ivig-and-inflammatory-bowel-disease-ibd\/\">other treatments<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"How_It_Works\"><\/span><strong>How It Works<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Your immune system becomes overactive in both ulcerative colitis and Crohn\u2019s disease. Your white blood cells mistakenly identify the cells in your gut lining as threats and attack them. As a result, inflammation occurs in your gut, and you experience symptoms associated with UC and Crohn\u2019s Disease, such as pain and diarrhea.&nbsp;<\/p>\n\n\n\n<p>Entyvio is a monoclonal antibody. It works by stopping white blood cells from entering your gut [<a href=\"https:\/\/content.takeda.com\/?contenttype=PI&amp;product=ENTY&amp;language=ENG&amp;country=USA&amp;documentnumber=1\">2<\/a>]. This action lessens inflammation and damage that these cells would typically cause. Unlike some other medications that affect the entire immune system, Entyvio specifically targets the gut. So, it can help reduce inflammation while minimizing side effects that would typically be seen with other medications.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Side_Effects\"><\/span><strong>Side Effects<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Like all medications, Entyvio can also cause side effects. These can range from common, mild reactions to more serious side effects. Here are some of the side effects of Entyvio [<a href=\"https:\/\/www.entyvio.com\/\">3<\/a>, <a href=\"https:\/\/www.entyviohcp.com\/safety-profile\">4<\/a>]:<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Common_Side_Effects\"><\/span><strong>Common Side Effects<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"420\" height=\"289\" src=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache.jpg\" alt=\"Woman suffering from headaches as a side effect of taking Entyvio\" class=\"wp-image-26539\" srcset=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache.jpg 420w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache-300x206.jpg 300w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache-86x59.jpg 86w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache-167x115.jpg 167w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache-280x193.jpg 280w, https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/headache-370x255.jpg 370w\" sizes=\"auto, (max-width: 420px) 100vw, 420px\" \/><\/figure>\n<\/div>\n\n\n<p>The most common side effects are:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Headaches<\/li>\n\n\n\n<li>Nausea<\/li>\n\n\n\n<li>Fever<\/li>\n\n\n\n<li>Joint pain<\/li>\n\n\n\n<li>Upper respiratory tract infections (e.g., colds, sinus infections)<\/li>\n\n\n\n<li>Pain, swelling, hives, or redness at the injection site<\/li>\n<\/ul>\n\n\n\n<p>These common side effects usually go away on their own after a short time. However, consult your healthcare provider if they worsen or do not go away.<\/p>\n\n\n\n<div  id=\"call-to-action-e9805a74ca60557b6c18396fc752def3\" style=\"\" class=\"ct_call_to_action\">\n\t<div class=\"container\">\n\t\t<div class=\"block-wrap cta\">\n\t\t\t<div class=\"block-column\">\n\t\t\t\t<div class=\"cta_headings\">\n\t\t\t\t\t\t\t\t\t\t\t<h4 class=\"cta__heading\">\n\t\t\t\t\t\t\tGet Financial Assistance\t\t\t\t\t\t<\/h4>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<span class=\"cta_btn\">\n\t\t\t\t\t\t<a href=\"#form\">Schedule a Consultation<\/a>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/div>\n\n\t\t<\/div>\n\t<\/div>\n<\/div>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Serious_Side_Effects\"><\/span><strong>Serious Side Effects<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Serious side effects for Entyvio are generally rare. Most people do not experience them, but they can still potentially occur. So, it\u2019s important to seek medical attention if you experience any of the following serious side effects of Entyvio:&nbsp;<\/p>\n\n\n\n<p><strong>Infusion-Related Reactions: <\/strong>You can experience infusion-related reactions during or shortly after the infusion. The symptoms include rash, itching, difficulty breathing, or chest pain. It\u2019s possible your healthcare provider might monitor you for these reactions for a bit of time after you receive your dose.<\/p>\n\n\n\n<p><strong>Infections: <\/strong>Entyvio can raise your risk of getting serious infections like sepsis or tuberculosis. Symptoms of an infection can include fever, chills, difficulty breathing, cough, and nasal congestion. Get medical attention if you experience any of these symptoms.<\/p>\n\n\n\n<p><strong>Progressive Multifocal Leukoencephalopathy (PML): <\/strong>PML is a serious brain infection caused by a virus that has no cure. People who have a weakened immune system can get it. Although unlikely, Entyvio can increase your chance of getting PML, as it weakens your immune system.<\/p>\n\n\n\n<p><strong>Liver Problems: <\/strong>Entyvio can cause serious liver problems. Symptoms of liver problems include dark urine, yellowing of the skin or eyes, or severe fatigue.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dosage_and_Treatment\"><\/span><strong>Dosage and Treatment<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Entyvio is available as a 300 mg lyophilized powder for injection. This medication is administered via intravenous (IV) infusion over about 30 minutes. Before starting treatment, make sure you are up-to-date with all necessary vaccinations. This is to ensure that your immune system is prepared to fight an infection because Entyvio lowers the activity of your immune system, which raises the risk of infections. The dosing schedule of Entyvio treatment is [<a href=\"https:\/\/content.takeda.com\/?contenttype=PI&amp;product=ENTY&amp;language=ENG&amp;country=USA&amp;documentnumber=1\">2<\/a>]:<br><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Initial Dose:<\/strong> The typical dose is 300 mg at week 0, week 2, and week 6.<\/li>\n\n\n\n<li><strong>Maintenance Dose:<\/strong> After the initial doses, you should receive an infusion every 8 weeks.<\/li>\n<\/ul>\n\n\n\n<p><strong>Note:<\/strong> If you don\u2019t see signs of improvement by the 14th week of treatment, you should talk to your prescriber about whether or not you should discontinue treatment with Entyvio.<strong>&nbsp;<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Cost\"><\/span><strong>Cost<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The cash price for Entyvio is $9,135 for a 300 mg powder for intravenous (IV) injection [<a href=\"https:\/\/www.drugs.com\/medical-answers\/entyvio-cost-month-3545103\/\">5<\/a>]. However, the real cost will depend on your insurance plan and location. You may also apply for Takeda Pharmaceutical\u2019s financial assistant program. If qualified, you could pay as low as $5 for each Entyvio dosage, up to a total benefit of $20,000 per year [<a href=\"https:\/\/www.entyvio.com\/copay-support\">6<\/a>].<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Entyvio_FAQs\"><\/span>Entyvio FAQs <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Here are some answers to frequently asked questions about Entyvio:<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>1. How long does it take for Entyvio to work?<\/strong><\/h4>\n\n\n\n<p>The time it takes for this medication to work varies from person to person. In clinical trials, some patients saw improvements in ulcerative colitis and Crohn\u2019s disease symptoms within 6 weeks of starting treatment [<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23964933\/\">7<\/a>]. But it can take up to 14 weeks to get the full effects of the medication. If there is no evidence of improvement by week 14, your healthcare provider may decide to stop the treatment.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>2. Is Entyvio safe to use during pregnancy or breastfeeding?<\/strong><\/h4>\n\n\n\n<p>The safety of Entyvio usage during pregnancy and breastfeeding is still unknown [<a href=\"https:\/\/content.takeda.com\/?contenttype=PI&amp;product=ENTY&amp;language=ENG&amp;country=USA&amp;documentnumber=1\">2<\/a>]. So, if you are pregnant, planning to become pregnant, or breastfeeding, consult with your healthcare provider first.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>3. Can I receive live vaccinations while on Entyvio?<\/strong><\/h4>\n\n\n\n<p>No, you can not. Entyvio usually weakens your immune system and increases your risk of getting an infection. Therefore, you should avoid live vaccines while receiving this medication. It\u2019s recommended that all necessary vaccinations be received before starting treatment.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Entyvio (vedolizumab) is a medication developed by Takeda Pharmaceuticals. The FDA first approved it on May 20, 2014 [1]. It is used to treat ulcerative colitis (UC) and Crohn\u2019s disease.\u00a0Entyvio is a type of medication called a monoclonal antibody that works by targeting specific parts of the immune system.<\/p>\n","protected":false},"author":26,"featured_media":26538,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":true,"om_disable_all_campaigns":false,"_uag_custom_page_level_css":"","footnotes":""},"categories":[4],"tags":[32],"class_list":["post-26537","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-other-health-conditions","tag-dr-robert-hakim"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease - AmeriPharma\u00ae Specialty Care<\/title>\n<meta name=\"description\" content=\"Learn how Entyvio can help treat ulcerative colitis and Crohn&#039;s disease. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease - AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"og:description\" content=\"Learn how Entyvio can help treat ulcerative colitis and Crohn&#039;s disease. Topics include how the drug works, side effects, dosage, and more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"AmeriPharma\u00ae Specialty Care\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ameripharma\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-12T18:42:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-12T18:42:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"853\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dr. Robert Hakim, PharmD\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Robert Hakim, PharmD\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/\"},\"author\":{\"name\":\"Dr. Robert Hakim, PharmD\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\"},\"headline\":\"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease\",\"datePublished\":\"2024-09-12T18:42:36+00:00\",\"dateModified\":\"2024-09-12T18:42:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/\"},\"wordCount\":1011,\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/ibd-patient.jpg\",\"keywords\":[\"Dr. Robert Hakim\"],\"articleSection\":[\"Other Health Conditions\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/\",\"name\":\"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease - AmeriPharma\u00ae Specialty Care\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/ibd-patient.jpg\",\"datePublished\":\"2024-09-12T18:42:36+00:00\",\"dateModified\":\"2024-09-12T18:42:38+00:00\",\"description\":\"Learn how Entyvio can help treat ulcerative colitis and Crohn's disease. Topics include how the drug works, side effects, dosage, and more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#primaryimage\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/ibd-patient.jpg\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/ibd-patient.jpg\",\"width\":1280,\"height\":853,\"caption\":\"Woman on a couch suffering from symptoms of IBD\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/other-health-conditions\\\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#website\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"name\":\"AmeriPharma\u00ae Specialty Care\",\"description\":\"Specialty Care by AmeriPharma\",\"publisher\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#organization\",\"name\":\"Ameripharma Specialty Care\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"contentUrl\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/specialty-care-logo-large-square.png\",\"width\":400,\"height\":400,\"caption\":\"Ameripharma Specialty Care\"},\"image\":{\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ameripharma\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/#\\\/schema\\\/person\\\/234280933b6e0dcaf47c0c1f40a59759\",\"name\":\"Dr. Robert Hakim, PharmD\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g\",\"caption\":\"Dr. Robert Hakim, PharmD\"},\"description\":\"Dr. Robert Chad Hakim, PharmD, was born and raised in Northridge, CA. He received his pharmacy degree from the University of Wisconsin-Madison School of Pharmacy. The most rewarding part of his job is taking initiative to advance clinical programs that maximize impact on patient care. He has a board certification in critical care (BCCCP), and his areas of expertise are critical care, drug information, general medicine, and cardiology. In his free time, he enjoys traveling.\u00a0\",\"url\":\"https:\\\/\\\/ameripharmaspecialty.com\\\/zh\\\/author\\\/robert-hakim\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Entyvio\uff1a\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u548c\u514b\u7f57\u6069\u75c5\u9776\u5411\u6cbb\u7597\u836f\u7269 - AmeriPharma\u00ae \u7279\u6548\u62a4\u7406","description":"\u4e86\u89e3 Entyvio \u5982\u4f55\u5e2e\u52a9\u6cbb\u7597\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u548c\u514b\u7f57\u6069\u75c5\u3002\u5185\u5bb9\u5305\u62ec\u836f\u7269\u7684\u4f5c\u7528\u673a\u5236\u3001\u526f\u4f5c\u7528\u3001\u5242\u91cf\u7b49\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/","og_locale":"zh_CN","og_type":"article","og_title":"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease - AmeriPharma\u00ae Specialty Care","og_description":"Learn how Entyvio can help treat ulcerative colitis and Crohn's disease. Topics include how the drug works, side effects, dosage, and more.","og_url":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/","og_site_name":"AmeriPharma\u00ae Specialty Care","article_publisher":"https:\/\/www.facebook.com\/ameripharma\/","article_published_time":"2024-09-12T18:42:36+00:00","article_modified_time":"2024-09-12T18:42:38+00:00","og_image":[{"width":1280,"height":853,"url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg","type":"image\/jpeg"}],"author":"Dr. Robert Hakim, PharmD","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Dr. Robert Hakim, PharmD","Est. reading time":"5 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#article","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/"},"author":{"name":"Dr. Robert Hakim, PharmD","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759"},"headline":"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease","datePublished":"2024-09-12T18:42:36+00:00","dateModified":"2024-09-12T18:42:38+00:00","mainEntityOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/"},"wordCount":1011,"publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg","keywords":["Dr. Robert Hakim"],"articleSection":["Other Health Conditions"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/","url":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/","name":"Entyvio\uff1a\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u548c\u514b\u7f57\u6069\u75c5\u9776\u5411\u6cbb\u7597\u836f\u7269 - AmeriPharma\u00ae \u7279\u6548\u62a4\u7406","isPartOf":{"@id":"https:\/\/ameripharmaspecialty.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#primaryimage"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#primaryimage"},"thumbnailUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg","datePublished":"2024-09-12T18:42:36+00:00","dateModified":"2024-09-12T18:42:38+00:00","description":"\u4e86\u89e3 Entyvio \u5982\u4f55\u5e2e\u52a9\u6cbb\u7597\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u548c\u514b\u7f57\u6069\u75c5\u3002\u5185\u5bb9\u5305\u62ec\u836f\u7269\u7684\u4f5c\u7528\u673a\u5236\u3001\u526f\u4f5c\u7528\u3001\u5242\u91cf\u7b49\u3002.","breadcrumb":{"@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#primaryimage","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg","width":1280,"height":853,"caption":"Woman on a couch suffering from symptoms of IBD"},{"@type":"BreadcrumbList","@id":"https:\/\/ameripharmaspecialty.com\/zh\/other-health-conditions\/entyvio-a-targeted-treatment-for-ulcerative-colitis-and-crohns-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ameripharmaspecialty.com\/"},{"@type":"ListItem","position":2,"name":"Entyvio: A Targeted Treatment for Ulcerative Colitis and Crohn\u2019s Disease"}]},{"@type":"WebSite","@id":"https:\/\/ameripharmaspecialty.com\/#website","url":"https:\/\/ameripharmaspecialty.com\/","name":"AmeriPharma\u00ae \u4e13\u4e1a\u62a4\u7406","description":"AmeriPharma \u7684\u4e13\u4e1a\u62a4\u7406","publisher":{"@id":"https:\/\/ameripharmaspecialty.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ameripharmaspecialty.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/ameripharmaspecialty.com\/#organization","name":"\u7f8e\u56fd\u5236\u836f\u4e13\u4e1a\u62a4\u7406","url":"https:\/\/ameripharmaspecialty.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/","url":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","contentUrl":"https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/07\/specialty-care-logo-large-square.png","width":400,"height":400,"caption":"Ameripharma Specialty Care"},"image":{"@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ameripharma\/"]},{"@type":"Person","@id":"https:\/\/ameripharmaspecialty.com\/#\/schema\/person\/234280933b6e0dcaf47c0c1f40a59759","name":"Robert Hakim\u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb","image":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1ce5316336fea18759f2cf91c9f6269796c7cb578013d4d04c78cb734056a87d?s=96&d=mm&r=g","caption":"Dr. Robert Hakim, PharmD"},"description":"Robert Chad Hakim \u535a\u58eb\uff0c\u836f\u5b66\u535a\u58eb\uff0c\u5728\u52a0\u5dde\u5317\u5cad\u51fa\u751f\u957f\u5927\u3002\u4ed6\u6bd5\u4e1a\u4e8e\u5a01\u65af\u5eb7\u661f\u5927\u5b66\u9ea6\u8fea\u900a\u5206\u6821\u836f\u5b66\u9662\uff0c\u83b7\u5f97\u836f\u5b66\u5b66\u4f4d\u3002\u5de5\u4f5c\u4e2d\u6700\u8ba9\u4ed6\u611f\u5230\u81ea\u8c6a\u7684\u662f\u79ef\u6781\u63a8\u8fdb\u4e34\u5e8a\u9879\u76ee\uff0c\u4ece\u800c\u6700\u5927\u9650\u5ea6\u5730\u63d0\u5347\u60a3\u8005\u62a4\u7406\u7684\u6548\u679c\u3002\u4ed6\u62e5\u6709\u91cd\u75c7\u76d1\u62a4\u59d4\u5458\u4f1a\u8ba4\u8bc1 (BCCCP)\uff0c\u4e13\u4e1a\u9886\u57df\u5305\u62ec\u91cd\u75c7\u76d1\u62a4\u3001\u836f\u7269\u4fe1\u606f\u3001\u5168\u79d1\u533b\u5b66\u548c\u5fc3\u810f\u75c5\u5b66\u3002\u95f2\u6687\u65f6\uff0c\u4ed6\u559c\u6b22\u65c5\u884c\u3002\u00a0","url":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"}]}},"uagb_featured_image_src":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-300x200.jpg",300,200,true],"medium_large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-768x512.jpg",768,512,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false]},"uagb_author_info":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"},"uagb_comment_info":0,"uagb_excerpt":"Entyvio (vedolizumab) is a medication developed by Takeda Pharmaceuticals. The FDA first approved it on May 20, 2014 [1]. It is used to treat ulcerative colitis (UC) and Crohn\u2019s disease.\u00a0Entyvio is a type of medication called a monoclonal antibody that works by targeting specific parts of the immune system.","rttpg_featured_image_url":{"full":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"landscape":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"portraits":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"thumbnail":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-150x150.jpg",150,150,true],"medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-300x200.jpg",300,200,true],"large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-1024x682.jpg",1024,682,true],"1536x1536":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"2048x2048":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false],"trp-custom-language-flag":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",18,12,false],"block-image-html-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-600x400.jpg",600,400,true],"ct-gallery":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-330x220.jpg",330,220,true],"ct-section-header":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-1146x380.jpg",1146,380,true],"ct-thumb":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-86x57.jpg",86,57,true],"ct-thumb-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-167x111.jpg",167,111,true],"ct-small":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-280x187.jpg",280,187,true],"ct-medium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-370x247.jpg",370,247,true],"ct-xmedium":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient-960x640.jpg",960,640,true],"ct-large":["https:\/\/ameripharmaspecialty.com\/wp-content\/uploads\/2024\/09\/ibd-patient.jpg",1280,853,false]},"rttpg_author":{"display_name":"Dr. Robert Hakim, PharmD","author_link":"https:\/\/ameripharmaspecialty.com\/zh\/author\/robert-hakim\/"},"rttpg_comment":0,"rttpg_category":"<a href=\"https:\/\/ameripharmaspecialty.com\/zh\/category\/other-health-conditions\/\" rel=\"category tag\">Other Health Conditions<\/a>","rttpg_excerpt":"Entyvio (vedolizumab) is a medication developed by Takeda Pharmaceuticals. The FDA first approved it on May 20, 2014 [1]. It is used to treat ulcerative colitis (UC) and Crohn\u2019s disease.\u00a0Entyvio is a type of medication called a monoclonal antibody that works by targeting specific parts of the immune system.","_links":{"self":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/26537","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/users\/26"}],"replies":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/comments?post=26537"}],"version-history":[{"count":0,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/posts\/26537\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media\/26538"}],"wp:attachment":[{"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/media?parent=26537"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/categories?post=26537"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ameripharmaspecialty.com\/zh\/wp-json\/wp\/v2\/tags?post=26537"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}